Company Filing History:
Years Active: 2020-2025
Title: Innovations of Shin Jung Park in Pharmaceutical Preparations
Introduction
Shin Jung Park is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of four patents to his name, Park's work focuses on enhancing the bioavailability and stability of pharmaceutical compositions.
Latest Patents
Among his latest patents, Park has developed a pharmaceutical preparation that boasts excellent dissolution properties, containing esomeprazole and sodium bicarbonate. This invention relates to a method of preparing a pharmaceutical preparation where sodium bicarbonate is first disintegrated to raise pH, allowing omeprazole to dissolve effectively. This process improves the release properties of the active ingredient, enhancing the dissolution pattern and bioavailability of the drug. Another significant patent is a stable pharmaceutical composition comprising esomeprazole and sodium bicarbonate. This composition is designed to improve stability with a low dose of sodium bicarbonate, which enhances the dissolution rate and bioavailability while minimizing side effects associated with higher doses.
Career Highlights
Shin Jung Park is currently associated with Chong Kun Dang Pharmaceutical Corporation, a leading company in the pharmaceutical industry. His work at the company has been instrumental in advancing the development of effective pharmaceutical products.
Collaborations
Park has collaborated with notable colleagues, including Jong Seo Choi and Min Soo Kim, contributing to the innovative research and development efforts within the company.
Conclusion
Shin Jung Park's contributions to pharmaceutical innovations demonstrate his commitment to improving drug formulations and patient outcomes. His patents reflect a deep understanding of pharmaceutical science and a dedication to enhancing the efficacy of medications.